Zimmer Biomet, the maker of knee and hip replacements, missed on quarterly sales estimates and lowered the top end of its outlook for full-year organic revenue growth.
This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here’s Why.
view original post